GRX News and Press, The Gabelli Healthcare & Wellness Trust of Beneficial Interest From 05/13/21

The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on June 23, 2021 to common shareholders of record on June 16, 2021. The Fund intends to pay a quarterly distribution...

Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare

The pace of recovery has begun to diverge across economies, with vaccination progress and the scale of government stimulus among the biggest swing factors. Macro disparities have also begun filtering into EPS growth expectations. Cyclically sensitive sectors have dominated the upg...

We still favor above-benchmark strategic allocations to China exposures, and see the recent weakness in Chinese markets offering an attractive entry point. The Federal Reserve made clear its commitment to be well "behind the curve" on inflation and wait to see it to materialize. I...

The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on March 24, 2021 to common shareholders of record on March 17, 2021. The Fund intends to pay a quarterly distributi...

If two strategies or portfolios are correlated highly enough (higher than 0.84), then their types of risk overlap sufficiently to be part of the same asset class or to serve the same strategic purpose in a portfolio. The demand for acute care has an inelastic demand curve, meaning tha...

I think we're not alone in being quite amazed by the resilience that the US market has shown following the very violent selloff in February and March. One of our big themes, digital innovation, continues to lead, transforming what I would call the more traditional or, sort of, classic...

HQL has outperformed other healthcare-oriented CEFs over the past year. It's selling at a -7.27% discount to NAV. It yields 7.94%, and is a good watchlist candidate. For further details see: Tekla Life Sciences Investors: 8% Yield, 7% Discount

GAMCO Investors, Inc., (NYSE: GBL) announces the appointment of Jennie Tsai, Jing He, and Sara Wojda to the investment team of the Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) effective January 1, 2021. Commenting on the appointments, Mr. Gabe...

The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) is pleased to announce the issuance of two million 4.00% Series C Cumulative Preferred Shares (“Series C Preferred”) with an aggregate liquidation value of $40...